.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

C3
Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet
Tech
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

C3
Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Videos
Start-Up
Planet

home
Topic
Piramal pharma

Piramal Pharma

Nandini Piramal, Chairperson, Piramal Pharma Ltd

US Biotech Funding, Rising M&A Signal Gradual CDMO Revival: Nandini Piramal

BY Vikash Tripathi

Piramal Pharma Posts ₹82 Cr Net Loss

Piramal Pharma Reports ₹82 Cr Net Loss in Q1 FY26

BY PTI

Piramal Group

Piramal Pharma Stock Surges 8% on Impressive Q2 Revenue Growth

BY Outlook Business Desk

Piramal Group

Piramal Pharma Board Approves Rs 1,050 Rights Issue At Rs 81 Per Share

BY Outlook Business Desk

Protesting Against Online Pharmacy, Chemists Observe Nationwide Shutdown Today

Piramal Pharma's Rs 1,050-Cr Rights Issue Gets Sebi's Nod

BY PTI

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

BY PTI

Piramal Pharma Locked In 5% Lower Circuit On Listing After Demerger

Piramal Pharma Locked In 5% Lower Circuit On Listing After Demerger

BY Outlook Business Desk

Advertisement

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

BY Press Trust of India

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.